Consensus Sight Sciences, Inc.

Equities

SGHT

US82657M1053

Real-time Estimate Cboe BZX Other stock markets 18:21:26 22/05/2024 BST			5-day change	1st Jan Change
5.405 ^USD	-1.01%		-2.61%	+4.75%

05-14	Transcript : Sight Sciences, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:15 AM
05-03	Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed	MT

Evolution of the average Target Price on Sight Sciences, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fe969c.ZcVIhoGPyQ5HfIJZSXjlGKBmT3VSMO7YUe9PFifbOsM.EYsc39P45GYATeovPBqIQZENIyEUUYjhY64qRx-dXJUOjTzz68qreXUfzw~5dd37fcd3fbcc8a4d29dcb486cb929d6

Analyst Recommendations on Sight Sciences, Inc.

Stifel Adjusts Price Target on Sight Sciences to $7 From $6, Keeps Buy Rating	03-08	MT
Morgan Stanley Adjusts Sight Sciences Price Target to $4 From $3, Maintains Equal Weight Rating	12-04	MT
Stifel Adjusts Price Target on Sight Sciences to $5 From $11, Maintains Buy Rating	18/09/23	MT
Citigroup Trims Price Target on Sight Sciences to $4 From $8, Maintains Neutral Rating	15/09/23	MT
Morgan Stanley Trims Price Target on Sight Sciences to $4 From $8.40, Maintains Equalweight Rating	13/09/23	MT
BofA Securities Downgrades Sight Sciences to Underperform From Neutral, Adjusts Price Target to $4.50 From $10	12/09/23	MT
William Blair Downgrades Sight Sciences to Market Perform From Outperform	12/09/23	MT
Piper Sandler Downgrades Sight Sciences to Neutral From Overweight, Adjusts Price Target to $5.50 From $15	12/09/23	MT
Morgan Stanley Downgrades Sight Sciences to Equalweight From Overweight, Adjusts Price Target to $8.40 From $12	24/08/23	MT
Citigroup Trims Sight Sciences Price Target to $8 From $9, Maintains Neutral Rating	21/08/23	MT
Citigroup Downgrades Sight Sciences to Neutral From Buy, Adjusts Price Target to $9 From $15	11/07/23	MT
Citigroup Downgrades Sight Sciences to Neutral From Buy, Lowers Price Target to $9 From $15	10/07/23	MT
Stifel Adjusts Price Target on Sight Sciences to $13 From $15, Maintains Buy Rating	26/06/23	MT
BofA Securities Adjusts Sight Sciences Price Target to $10 From $13, Maintains Buy Rating	06/06/23	MT
Morgan Stanley Adjusts Sight Sciences' Price Target to $15 From $11, Keeps Overweight Rating	06/01/23	MT
Stifel Nicolaus Upgrades Sight Sciences to Buy From Hold, Adjusts Price Target to $15 From $10	06/01/23	MT
Citigroup Adjusts Price Target on Sight Sciences to $15 From $10, Maintains Buy Rating	12/12/22	MT
Morgan Stanley Adjusts Sight Sciences' Price Target to $10 from $14, Maintains Overweight Rating	11/10/22	MT
Needham Initiates Sight Sciences at Hold, Says While Dry Eye Business Potentially 'Significant Revenue Growth Driver,' Market Development Likely 'to Take Time, Further Investment'	04/10/22	MT
Morgan Stanley Adjusts Price Target on Sight Sciences to $14 From $17, Reiterates Overweight Rating	12/08/22	MT
Piper Sandler Adjusts Price Target on Sight Sciences to $15 From $17, Reiterates Overweight Rating	12/08/22	MT
Stifel Initiates Sight Sciences at Hold With $10 Price Target	26/07/22	MT
Morgan Stanley Adjusts Price Target on Sight Sciences to $17 From $18, Keeps Overweight Rating	15/07/22	MT
Piper Sandler Lowers Sight Sciences Price Target to $17 From $23, Maintains Overweight Rating	11/05/22	MT
Citigroup Adjusts Sight Sciences' Price Target to $35 From $39, Reiterates Buy Rating	25/03/22	MT